Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis (MIRROR)
The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart.
Trimesta in relapsing-remitting multiple sclerosis patients (Phase II)
Complexity of trophic factor signaling in experimental autoimmune encephalomyelitis: Differential expression of neurotrophic and gliotrophic factors.
Toxicity of Teriflunomide in Aryl Hydrocarbon Receptor Deficient Mice.
NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels.
Treatment Optimization in MS: Canadian MS Working Group Updated Recommendations.
RILUTEK®
BTG plc Close Period Update
Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model.
Arzerra
Long extensive transverse myelitis associated with aquaporin-4 antibody and breast cancer: Favorable response to cancer treatment.
Radiologic MS disease activity during natalizumab treatment interruption: findings from RESTORE.
Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis.
Minocycline inhibits antigen processing for presentation to human T cells: additive inhibition with chloroquine at therapeutic concentrations.
The correlation between symptomatic fatigue to definite measures of gait in people with multiple sclerosis.
The Inaugural Hillel Panitch, MD Multiple Sclerosis Symposium
Varicella zoster-associated retinal and central nervous system vasculitis in a patient with multiple sclerosis treated with natalizumab.
ALSUntangled No. 8: Low dose naltrexone for ALS.
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study.
Impact of sleep disorder treatment on fatigue in multiple sclerosis.
Receptos announces issuance of composition of matter patents covering proprietary lead product candidate RPC1063
Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis (ITT-PMS)
Monomethyl fumarate promotes Nrf2-dependent neuroprotection in retinal ischemia-reperfusion.
Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases.

Pages